A Study to Compare Upadacitinib (ABT-494) to Placebo in Adults With Rheumatoid Arthritis on Stable Dose of Conventional Synthetic Disease-Modifying Antirheumatic Drugs (csDMARDs) With an Inadequate Response or Intolerance to Biologic DMARDs
Clinical trial NCT02706847 · COMPLETED
Trial details
- NCT number
- NCT02706847
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-15
- Primary completion
- 2017-04-03
- Enrollment
- 499
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.